0.00Open0.11Pre Close0 Volume16 Open Interest68.00Strike Price0.00Turnover441.62%IV15.06%PremiumDec 27, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.11Extrinsic Value100Contract SizeAmericanOptions Type-0.0365Delta0.0109Gamma726.61Leverage Ratio-1.7608Theta0.0000Rho-26.54Eff Leverage0.0013Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet